Immunovant anticipates initiating clinical trials evaluating IMVT-1402 in a total of ten indications by March 31, 2026. Neurology Program: ...

While most recover, early treatment is critical ... The major subtypes include: Acute Inflammatory Demyelinating Polyneuropathy (AIDP): The most common form in Western countries, characterized ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Joel Kaufman, a physician-epidemiologist at the University of Washington, said increases in certain chronic diseases could have to do with improvements in the prevention and treatment of ...

Country music star Carly Pearce is sharing a health update after she was diagnosed with a heart condition called pericarditis. The 34-year-old singer detailed her “intense” symptoms during an ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are major complications that occur in severely ill patients who require intensive care treatment. CIP and CIM affect the ...

But doctors are rushed in appointments, and having to make a diagnosis and come up with a treatment plan already takes up more time than is allotted for most appointments. And with a disease like CIDP ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...